Connect with us

Business

Broker laments ‘catastrophic negative surprise’ that highlights the risks with these types of ASX shares

Published

9 months ago

on

April 5, 2025

By

Noosa Online News Publisher

ASX share Opthea Limited (ASX: OPT) remains suspended from trading as the biotech company works to avoid insolvency.

Opthea last traded at 60 cents per share.

Last week, we learned that Opthea has decided to cease development of its flagship sozinibercept (OPT-302) treatment.

OPT-302 had…

Click here to view the original article.

Related Topics:fool.com.au

10 ASX shares to buy after the market selloff

How buying stocks in the Covid pandemic made me a better investor today

Continue Reading

Advertisement

General18 hours ago

Four escape injury after jumping from three-storey unit on fire in Newcastle

Noosa News18 hours ago

Gippsland vegetable farm accused of underpaying migrant workers

General23 hours ago

De-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says

Noosa News19 hours ago

The Best Things to Do in Brisbane This New Year’s Eve

About Us	Contact Us

© 2025 Noosa Online News
Privacy Policy